Browse the corpus

REFERENCES ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group, “Major Outcomes in High-Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT),” JAMA , 2002, 288(23):2981-97. [PubMed 12479763 ] Antman EM, Anbe DT, Armstrong PW, et al, “ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction - Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction),” Circulation , 2004, 110:588-636. [PubMed 15289388 ] Baker-Smith CM, Benjamin DK Jr, Califf RM, et al, "Cough in Pediatric Patients Receiving Angiotensin-Converting Enzyme Inhibitor Therapy or Angiotensin Receptor Blocker Therapy in Randomized Controlled Trials," Clin Pharmacol Ther , 2010, 87(6):668-71. [PubMed 20130570 ] Brown NJ, Ray WA, Snowden M, et al, “Black Americans Have an Increased Rate of Angiotensin-Converting Enzyme Inhibitor-Associated Angioedema,” Clin Pharmacol Ther , 1996, 60(1):8-13. [PubMed 8689816 ] Chase MP, Fiarman GS, Scholz FJ, et al, “Angioedema of the Small Bowel Due to an Angiotensin-Converting Enzyme Inhibitor,” J Clin Gastroenterol , 2000, 31(3):254-7. [PubMed 11034011 ] Chobanian AV, Bakris GL, Black HR, et al, “The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 Report,” JAMA , 2003, 289(19):2560-72. [PubMed 12748199 ] Conlin PR, Moore TJ, Swartz SL, et al, “Effect of Indomethacin on Blood Pressure Lowering by Captopril and Losartan in Hypertensive Patients,” Hypertension , 2000, 36(3):461-5. [PubMed 10988282 ] “Consensus Recommendations for the Management of Chronic Heart Failure. On Behalf of the Membership of the Advisory Council to Improve Outcomes Nationwide in Heart Failure,” Am J Cardiol , 1999, 83(2A):1A-38A. [PubMed 10072251 ] Cooper WO, Hernandez-Diaz S, Arbogast PG, et al, “Major Congenital Malformations After First-Trimester Exposure to ACE Inhibitors,” N Engl J Med , 2006, 354(23):2443-51. [PubMed 16760444 ]

“Consensus Recommendations for the Management of Chronic Heart Failure. On Behalf of the Membership of the Advisory Council to Improve Outcomes Nationwide in Heart Failure,” Am J Cardiol , 1999, 83(2A):1A-38A. [PubMed 10072251 ] Cooper WO, Hernandez-Diaz S, Arbogast PG, et al, “Major Congenital Malformations After First-Trimester Exposure to ACE Inhibitors,” N Engl J Med , 2006, 354(23):2443-51. [PubMed 16760444 ] “Guidelines for the Evaluation and Management of Heart Failure. Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Evaluation and Management of Heart Failure),” Circulation , 1995, 92(9):2764-84. [PubMed 7594057 ] Kaiser G, Ackermann R, Brechbühler S, et al, "Pharmacokinetics of the Angiotensin Converting Enzyme Inhibitor Benazepril.HCl (CGS 14 824 A) in Healthy Volunteers After Single and Repeated Administration," Biopharm Drug Dispos , 1989, 10(4):365-76. [PubMed 2758102 ] “K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification, and Stratification. Kidney Disease Outcome Quality Initiative,” Am J Kidney Dis , 2002, 39(2 Suppl 2):1-246. Konstam MA, Dracup K, Baker, DW, et al, “Heart Failure Evaluation and Care of Patients With Left-Ventricular Systolic Dysfunction,” J Card Fail , 1995, 1(2):183-7. [PubMed 9420649 ] Mastrobattista JM, “Angiotensin Converting Enzyme Inhibitors in Pregnancy,” Semin Perinatol , 1997, 21(2):124-34. [PubMed 9201818 ] National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents, "The Fourth Report on the Diagnosis, Evaluation, and Treatment of High Blood Pressure in Children and Adolescents," Pediatrics , 2004, 114(2 Suppl):555-76. [PubMed 15286277 ] Packer M, Poole-Wilson PA, Armstrong PW, et al, “Comparative Effects of Low and High Doses of the Angiotensin-Converting Enzyme Inhibitor, Lisinopril, on Morbidity and Mortality in Chronic Heart Failure,” Circulation , 1999, 100(23):2312-8. [PubMed 1058733 ] Quan A, “Fetopathy Associated With Exposure to Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Antagonists,” Early Hum Dev , 2006, 82(1):23-8. [PubMed 16427219 ] Smoger SH and Sayed MA, “Simultaneous Mucosal and Small Bowel Angioedema Due to Captopril,” South Med J , 1998, 91(11):1060-3. [PubMed 9824192 ]

Quan A, “Fetopathy Associated With Exposure to Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Antagonists,” Early Hum Dev , 2006, 82(1):23-8. [PubMed 16427219 ] Smoger SH and Sayed MA, “Simultaneous Mucosal and Small Bowel Angioedema Due to Captopril,” South Med J , 1998, 91(11):1060-3. [PubMed 9824192 ] von Vigier RO, Mozzettini S, Truttmann AC, et al, “Cough is Common in Children Prescribed Converting Enzyme Inhibitors,” Nephron , 2000, 84(1):98. [PubMed 10644922 ] Topic 12871 Version 40.0 © 2013 UpToDate, Inc. All rights reserved. | Subscription and License Agreement | Release: 21.3 - C21.34 Licensed to: Morehouse School of Medicine | Support Tag: [1003-200.150.3.100-CF9877BBA9-S473950.14]